Women's health portfolio spanning contraceptives, hormone therapy, and prenatal supplements.
Ginecológicos is Libbs Farmacêutica's gynecology portfolio, developed over more than twenty years and presented on a dedicated official page for healthcare professionals. It lists twenty products including combined and progestin-only contraceptives such as Nextela (estetrol/drospirenone), Elani, Iumi, Diminut, Gestinol, Minian, Nactali, Pozato Uni, and Siblima.
Hormone therapy for menopause and climacteric symptoms is covered by Natifa, Natifa Pro, Ceci, and Libiam (tibolone), while supplements include Matrion (active folate with B6/B12), probiotic Zaila (L. rhamnosus GR-1 and L. reuteri RC-14), and the Belamy intimate moisturizing gel.
| Attribute | Ginecológicos | Mirena | Women's Health | Women's Healthcare | |
|---|---|---|---|---|---|
| Provider | |  |  |  | |
| Founded | 1958 | 1863 | 2003 | 1901 | |
| Sells To | Consumers, Enterprise | Consumers, Enterprise | — | Consumers | |
| Pricing Model | Recurring, Software | Recurring, Software, Transactional | — | Recurring, Software, Transactional | |
| Ownership | Private | Public | — | Public |
Provider
Founded 1958
Sells To Consumers, Enterprise
Pricing Model Recurring, Software
Ownership Private
Founded 1863
Sells To Consumers, Enterprise
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider
Founded 2003
Sells To —
Pricing Model —
Ownership —
Provider
Founded 1901
Sells To Consumers
Pricing Model Recurring, Software, Transactional
Ownership Public
Bayer's Hormonal & Reproductive Health area covers contraception, menopause, endometriosis and related women's health therapies.
Organon's Women's Health portfolio addresses contraception, fertility, menopause and other women's health conditions across more than 140 markets.
Patented intrauterine device insertion system in preclinical development that consolidates IUD placement instruments.
Bayer's Hormonal & Reproductive Health area covers contraception, menopause, endometriosis and related women's health therapies.
Organon's Women's Health portfolio addresses contraception, fertility, menopause and other women's health conditions across more than 140 markets.
Patented intrauterine device insertion system in preclinical development that consolidates IUD placement instruments.
